MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,697,395 | +22.8% | 275,234 | +0.5% | 0.00% | +100.0% |
| Q2 2023 | $7,084,733 | +37.7% | 273,859 | +27.9% | 0.00% | 0.0% |
| Q1 2023 | $5,145,012 | +24.1% | 214,197 | +0.7% | 0.00% | 0.0% |
| Q4 2022 | $4,147,358 | -5.2% | 212,685 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $4,373,000 | +27.1% | 208,162 | +17.8% | 0.00% | 0.0% |
| Q2 2022 | $3,440,000 | +81.0% | 176,766 | +104.8% | 0.00% | – |
| Q1 2022 | $1,901,000 | +33.6% | 86,327 | -3.3% | 0.00% | – |
| Q4 2021 | $1,423,000 | -19.5% | 89,235 | +0.6% | 0.00% | – |
| Q3 2021 | $1,768,000 | +6.5% | 88,745 | -7.5% | 0.00% | – |
| Q2 2021 | $1,660,000 | -13.6% | 95,978 | -1.0% | 0.00% | – |
| Q1 2021 | $1,921,000 | +11.9% | 96,935 | -1.4% | 0.00% | – |
| Q4 2020 | $1,716,000 | -11.8% | 98,334 | -2.6% | 0.00% | – |
| Q3 2020 | $1,946,000 | -0.4% | 100,989 | +0.6% | 0.00% | – |
| Q2 2020 | $1,953,000 | +99.7% | 100,354 | +43.6% | 0.00% | – |
| Q1 2020 | $978,000 | -14.4% | 69,906 | +50.0% | 0.00% | – |
| Q4 2019 | $1,142,000 | +208.6% | 46,612 | +26.6% | 0.00% | – |
| Q3 2019 | $370,000 | – | 36,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,621,118 | $38,939,254 | 45.05% |
| NEA Management Company, LLC | 4,186,243 | $100,553,557 | 6.95% |
| Frazier Life Sciences Management, L.P. | 3,860,107 | $92,719,770 | 6.71% |
| Prosight Management, LP | 567,826 | $13,639,181 | 6.47% |
| TANG CAPITAL MANAGEMENT LLC | 1,170,000 | $28,103,400 | 4.19% |
| Highlander Partners, L.P. | 122,980 | $2,953,980 | 4.00% |
| Novo Holdings A/S | 1,684,193 | $40,454,316 | 2.67% |
| CADIAN CAPITAL MANAGEMENT, LP | 734,922 | $17,652,826 | 1.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,032,335 | $48,816,687 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,939 | $2,544,655 | 1.05% |